EE80 The Potential Clinical and Economic Benefits of a Next Generation Omicron-Containing (BA.1) Bivalent Sars-Cov-2 Booster Compared to First Generation Prototype Boosters in Germany Assuming BA.4/BA.5 Dominance

Authors :: M Maschio
B Schweikert
B Ultsch
R Cai
K Fust
A Lee
A Nasir
P Buck
N Van de Velde
M Kohli
Source :: Value in Health. 25:S68-S69
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Subjects :: Health Policy
Public Health, Environmental and Occupational Health

Full Text Access

Tools